 | • レポートコード：D0GIR-00256 • 出版社/出版日：GlobalInfoResearch / 2020年9月18日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、100ページ • 納品方法：Eメール • 産業分類：医療、製薬、バイオ |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、薬物動態の世界市場を広く調査・分析し、今後の市場展望をまとめております。薬物動態の種類別市場規模（非コンパートメント法、コンパートメント法）、用途別市場規模（腫瘍学、心臓血管疾患、感染症、自己免疫疾患、呼吸器疾患、神経疾患、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェアなどの情報を掲載しています。 ・市場概要 ・企業情報（販売量、市場シェア、製品概要、SWOT分析）：Charles River Laboratories、Parexel、Drumetix Laboratories、Covance、LGC、Cyprotex、TCG Lifesciences、GVK Biosciences、Eurofins Scientific、Pharmoptima ・地域別グローバル市場分析 2015年-2020年 ・薬物動態の北米市場（アメリカ、カナダ、メキシコ） ・薬物動態のヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・薬物動態のアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・薬物動態の南米市場（ブラジル、アルゼンチン） ・薬物動態の中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：非コンパートメント法、コンパートメント法 ・用途別分析：腫瘍学、心臓血管疾患、感染症、自己免疫疾患、呼吸器疾患、神経疾患、その他 ・地域別市場規模予測 2021年-2025年 ・調査の結果・結論 |
Market Overview
The global Pharmacokinetics market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
The Pharmacokinetics market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Pharmacokinetics market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Pharmacokinetics market has been segmented into:
Noncompartmental Methods
Compartmental Methods
By Application, Pharmacokinetics has been segmented into:
Oncology
Cardiovascular Diseases
Infectious Diseases
Autoimmune Diseases
Respiratory Disorders
Neurological Disorders
Others
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Pharmacokinetics market presented in the report. This section sheds light on the sales growth of different regional and country-level Pharmacokinetics markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Pharmacokinetics market.
The report offers in-depth assessment of the growth and other aspects of the Pharmacokinetics market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Competitive Landscape and Pharmacokinetics Market Share Analysis
Pharmacokinetics competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Pharmacokinetics sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Pharmacokinetics sales, revenue and market share for each player covered in this report.
The major players covered in Pharmacokinetics are:
Charles River Laboratories
Parexel
Drumetix Laboratories
Covance
LGC
Cyprotex
TCG Lifesciences
GVK Biosciences
Eurofins Scientific
Pharmoptima
Table of Contents
1 Pharmacokinetics Market Overview
1.1 Product Overview and Scope of Pharmacokinetics
1.2 Classification of Pharmacokinetics by Type
1.2.1 Global Pharmacokinetics Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Pharmacokinetics Revenue Market Share by Type in 2019
1.2.3 Noncompartmental Methods
1.2.4 Compartmental Methods
1.3 Global Pharmacokinetics Market by Application
1.3.1 Overview: Global Pharmacokinetics Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Oncology
1.3.3 Cardiovascular Diseases
1.3.4 Infectious Diseases
1.3.5 Autoimmune Diseases
1.3.6 Respiratory Disorders
1.3.7 Neurological Disorders
1.3.8 Others
1.4 Global Pharmacokinetics Market by Regions
1.4.1 Global Pharmacokinetics Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Pharmacokinetics (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Pharmacokinetics Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Pharmacokinetics Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Pharmacokinetics Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Pharmacokinetics Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Pharmacokinetics Status and Prospect (2015-2025)
2 Company Profiles
2.1 Charles River Laboratories
2.1.1 Charles River Laboratories Details
2.1.2 Charles River Laboratories Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Charles River Laboratories SWOT Analysis
2.1.4 Charles River Laboratories Product and Services
2.1.5 Charles River Laboratories Pharmacokinetics Revenue, Gross Margin and Market Share (2018-2019)
2.2 Parexel
2.2.1 Parexel Details
2.2.2 Parexel Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Parexel SWOT Analysis
2.2.4 Parexel Product and Services
2.2.5 Parexel Pharmacokinetics Revenue, Gross Margin and Market Share (2018-2019)
2.3 Drumetix Laboratories
2.3.1 Drumetix Laboratories Details
2.3.2 Drumetix Laboratories Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Drumetix Laboratories SWOT Analysis
2.3.4 Drumetix Laboratories Product and Services
2.3.5 Drumetix Laboratories Pharmacokinetics Revenue, Gross Margin and Market Share (2018-2019)
2.4 Covance
2.4.1 Covance Details
2.4.2 Covance Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Covance SWOT Analysis
2.4.4 Covance Product and Services
2.4.5 Covance Pharmacokinetics Revenue, Gross Margin and Market Share (2018-2019)
2.5 LGC
2.5.1 LGC Details
2.5.2 LGC Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 LGC SWOT Analysis
2.5.4 LGC Product and Services
2.5.5 LGC Pharmacokinetics Revenue, Gross Margin and Market Share (2018-2019)
2.6 Cyprotex
2.6.1 Cyprotex Details
2.6.2 Cyprotex Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Cyprotex SWOT Analysis
2.6.4 Cyprotex Product and Services
2.6.5 Cyprotex Pharmacokinetics Revenue, Gross Margin and Market Share (2018-2019)
2.7 TCG Lifesciences
2.7.1 TCG Lifesciences Details
2.7.2 TCG Lifesciences Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 TCG Lifesciences SWOT Analysis
2.7.4 TCG Lifesciences Product and Services
2.7.5 TCG Lifesciences Pharmacokinetics Revenue, Gross Margin and Market Share (2018-2019)
2.8 GVK Biosciences
2.8.1 GVK Biosciences Details
2.8.2 GVK Biosciences Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 GVK Biosciences SWOT Analysis
2.8.4 GVK Biosciences Product and Services
2.8.5 GVK Biosciences Pharmacokinetics Revenue, Gross Margin and Market Share (2018-2019)
2.9 Eurofins Scientific
2.9.1 Eurofins Scientific Details
2.9.2 Eurofins Scientific Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Eurofins Scientific SWOT Analysis
2.9.4 Eurofins Scientific Product and Services
2.9.5 Eurofins Scientific Pharmacokinetics Revenue, Gross Margin and Market Share (2018-2019)
2.10 Pharmoptima
2.10.1 Pharmoptima Details
2.10.2 Pharmoptima Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Pharmoptima SWOT Analysis
2.10.4 Pharmoptima Product and Services
2.10.5 Pharmoptima Pharmacokinetics Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Pharmacokinetics Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Pharmacokinetics Players Market Share
3.2.2 Top 10 Pharmacokinetics Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Pharmacokinetics Revenue and Market Share by Regions
4.2 North America Pharmacokinetics Revenue and Growth Rate (2015-2020)
4.3 Europe Pharmacokinetics Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Pharmacokinetics Revenue and Growth Rate (2015-2020)
4.5 South America Pharmacokinetics Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Pharmacokinetics Revenue and Growth Rate (2015-2020)
5 North America Pharmacokinetics Revenue by Countries
5.1 North America Pharmacokinetics Revenue by Countries (2015-2020)
5.2 USA Pharmacokinetics Revenue and Growth Rate (2015-2020)
5.3 Canada Pharmacokinetics Revenue and Growth Rate (2015-2020)
5.4 Mexico Pharmacokinetics Revenue and Growth Rate (2015-2020)
6 Europe Pharmacokinetics Revenue by Countries
6.1 Europe Pharmacokinetics Revenue by Countries (2015-2020)
6.2 Germany Pharmacokinetics Revenue and Growth Rate (2015-2020)
6.3 UK Pharmacokinetics Revenue and Growth Rate (2015-2020)
6.4 France Pharmacokinetics Revenue and Growth Rate (2015-2020)
6.5 Russia Pharmacokinetics Revenue and Growth Rate (2015-2020)
6.6 Italy Pharmacokinetics Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Pharmacokinetics Revenue by Countries
7.1 Asia-Pacific Pharmacokinetics Revenue by Countries (2015-2020)
7.2 China Pharmacokinetics Revenue and Growth Rate (2015-2020)
7.3 Japan Pharmacokinetics Revenue and Growth Rate (2015-2020)
7.4 Korea Pharmacokinetics Revenue and Growth Rate (2015-2020)
7.5 India Pharmacokinetics Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Pharmacokinetics Revenue and Growth Rate (2015-2020)
8 South America Pharmacokinetics Revenue by Countries
8.1 South America Pharmacokinetics Revenue by Countries (2015-2020)
8.2 Brazil Pharmacokinetics Revenue and Growth Rate (2015-2020)
8.3 Argentina Pharmacokinetics Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Pharmacokinetics by Countries
9.1 Middle East & Africa Pharmacokinetics Revenue by Countries (2015-2020)
9.2 Saudi Arabia Pharmacokinetics Revenue and Growth Rate (2015-2020)
9.3 UAE Pharmacokinetics Revenue and Growth Rate (2015-2020)
9.4 Egypt Pharmacokinetics Revenue and Growth Rate (2015-2020)
9.5 South Africa Pharmacokinetics Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Pharmacokinetics Revenue and Market Share by Type (2015-2020)
10.2 Global Pharmacokinetics Market Forecast by Type (2019-2024)
10.3 Noncompartmental Methods Revenue Growth Rate (2015-2025)
10.4 Compartmental Methods Revenue Growth Rate (2015-2025)
11 Global Pharmacokinetics Market Segment by Application
11.1 Global Pharmacokinetics Revenue Market Share by Application (2015-2020)
11.2 Pharmacokinetics Market Forecast by Application (2019-2024)
11.3 Oncology Revenue Growth (2015-2020)
11.4 Cardiovascular Diseases Revenue Growth (2015-2020)
11.5 Infectious Diseases Revenue Growth (2015-2020)
11.6 Autoimmune Diseases Revenue Growth (2015-2020)
11.7 Respiratory Disorders Revenue Growth (2015-2020)
11.8 Neurological Disorders Revenue Growth (2015-2020)
11.9 Others Revenue Growth (2015-2020)
12 Global Pharmacokinetics Market Size Forecast (2021-2025)
12.1 Global Pharmacokinetics Market Size Forecast (2021-2025)
12.2 Global Pharmacokinetics Market Forecast by Regions (2021-2025)
12.3 North America Pharmacokinetics Revenue Market Forecast (2021-2025)
12.4 Europe Pharmacokinetics Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Pharmacokinetics Revenue Market Forecast (2021-2025)
12.6 South America Pharmacokinetics Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Pharmacokinetics Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US
Table 1. Global Pharmacokinetics Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Pharmacokinetics by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Pharmacokinetics Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Pharmacokinetics Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Charles River Laboratories Corporate Information, Location and Competitors
Table 6. Charles River Laboratories Pharmacokinetics Major Business
Table 7. Charles River Laboratories Pharmacokinetics Total Revenue (USD Million) (2017-2018)
Table 8. Charles River Laboratories SWOT Analysis
Table 9. Charles River Laboratories Pharmacokinetics Product and Solutions
Table 10. Charles River Laboratories Pharmacokinetics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 11. Parexel Corporate Information, Location and Competitors
Table 12. Parexel Pharmacokinetics Major Business
Table 13. Parexel Pharmacokinetics Total Revenue (USD Million) (2018-2019)
Table 14. Parexel SWOT Analysis
Table 15. Parexel Pharmacokinetics Product and Solutions
Table 16. Parexel Pharmacokinetics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 17. Drumetix Laboratories Corporate Information, Location and Competitors
Table 18. Drumetix Laboratories Pharmacokinetics Major Business
Table 19. Drumetix Laboratories Pharmacokinetics Total Revenue (USD Million) (2017-2018)
Table 20. Drumetix Laboratories SWOT Analysis
Table 21. Drumetix Laboratories Pharmacokinetics Product and Solutions
Table 22. Drumetix Laboratories Pharmacokinetics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 23. Covance Corporate Information, Location and Competitors
Table 24. Covance Pharmacokinetics Major Business
Table 25. Covance Pharmacokinetics Total Revenue (USD Million) (2017-2018)
Table 26. Covance SWOT Analysis
Table 27. Covance Pharmacokinetics Product and Solutions
Table 28. Covance Pharmacokinetics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 29. LGC Corporate Information, Location and Competitors
Table 30. LGC Pharmacokinetics Major Business
Table 31. LGC Pharmacokinetics Total Revenue (USD Million) (2017-2018)
Table 32. LGC SWOT Analysis
Table 33. LGC Pharmacokinetics Product and Solutions
Table 34. LGC Pharmacokinetics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 35. Cyprotex Corporate Information, Location and Competitors
Table 36. Cyprotex Pharmacokinetics Major Business
Table 37. Cyprotex Pharmacokinetics Total Revenue (USD Million) (2017-2018)
Table 38. Cyprotex SWOT Analysis
Table 39. Cyprotex Pharmacokinetics Product and Solutions
Table 40. Cyprotex Pharmacokinetics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 41. TCG Lifesciences Corporate Information, Location and Competitors
Table 42. TCG Lifesciences Pharmacokinetics Major Business
Table 43. TCG Lifesciences Pharmacokinetics Total Revenue (USD Million) (2017-2018)
Table 44. TCG Lifesciences SWOT Analysis
Table 45. TCG Lifesciences Pharmacokinetics Product and Solutions
Table 46. TCG Lifesciences Pharmacokinetics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 47. GVK Biosciences Corporate Information, Location and Competitors
Table 48. GVK Biosciences Pharmacokinetics Major Business
Table 49. GVK Biosciences Pharmacokinetics Total Revenue (USD Million) (2017-2018)
Table 50. GVK Biosciences SWOT Analysis
Table 51. GVK Biosciences Pharmacokinetics Product and Solutions
Table 52. GVK Biosciences Pharmacokinetics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 53. Eurofins Scientific Corporate Information, Location and Competitors
Table 54. Eurofins Scientific Pharmacokinetics Major Business
Table 55. Eurofins Scientific Pharmacokinetics Total Revenue (USD Million) (2017-2018)
Table 56. Eurofins Scientific SWOT Analysis
Table 57. Eurofins Scientific Pharmacokinetics Product and Solutions
Table 58. Eurofins Scientific Pharmacokinetics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 59. Pharmoptima Corporate Information, Location and Competitors
Table 60. Pharmoptima Pharmacokinetics Major Business
Table 61. Pharmoptima Pharmacokinetics Total Revenue (USD Million) (2017-2018)
Table 62. Pharmoptima SWOT Analysis
Table 63. Pharmoptima Pharmacokinetics Product and Solutions
Table 64. Pharmoptima Pharmacokinetics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 65. Global Pharmacokinetics Revenue (Million USD) by Players (2015-2020)
Table 66. Global Pharmacokinetics Revenue Share by Players (2015-2020)
Table 67. Global Pharmacokinetics Revenue (Million USD) by Regions (2015-2020)
Table 68. Global Pharmacokinetics Revenue Market Share by Regions (2015-2020)
Table 69. North America Pharmacokinetics Revenue by Countries (2015-2020)
Table 70. North America Pharmacokinetics Revenue Market Share by Countries (2015-2020)
Table 71. Europe Pharmacokinetics Revenue (Million USD) by Countries (2015-2020)
Table 72. Asia-Pacific Pharmacokinetics Revenue (Million USD) by Countries (2015-2020)
Table 73. South America Pharmacokinetics Revenue by Countries (2015-2020)
Table 74. South America Pharmacokinetics Revenue Market Share by Countries (2015-2020)
Table 75. Middle East and Africa Pharmacokinetics Revenue (Million USD) by Countries (2015-2020)
Table 76. Middle East and Africa Pharmacokinetics Revenue Market Share by Countries (2015-2020)
Table 77. Global Pharmacokinetics Revenue (Million USD) by Type (2015-2020)
Table 78. Global Pharmacokinetics Revenue Share by Type (2015-2020)
Table 79. Global Pharmacokinetics Revenue Forecast by Type (2021-2025)
Table 80. Global Pharmacokinetics Revenue by Application (2015-2020)
Table 81. Global Pharmacokinetics Revenue Share by Application (2015-2020)
Table 82. Global Pharmacokinetics Revenue Forecast by Application (2021-2025)
Table 83. Global Pharmacokinetics Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Pharmacokinetics Picture
Figure 2. Global Pharmacokinetics Revenue Market Share by Type in 2019
Figure 3. Noncompartmental Methods Picture
Figure 4. Compartmental Methods Picture
Figure 5. Pharmacokinetics Revenue Market Share by Application in 2019
Figure 6. Oncology Picture
Figure 7. Cardiovascular Diseases Picture
Figure 8. Infectious Diseases Picture
Figure 9. Autoimmune Diseases Picture
Figure 10. Respiratory Disorders Picture
Figure 11. Neurological Disorders Picture
Figure 12. Others Picture
Figure 13. Global Pharmacokinetics Revenue (USD Million) and Growth Rate (2015-2025)
Figure 14. North America Pharmacokinetics Revenue (Million USD) and Growth Rate (2015-2025)
Figure 15. Europe Pharmacokinetics Revenue (Million USD) and Growth Rate (2015-2025)
Figure 16. Asia-Pacific Pharmacokinetics Revenue (Million USD) and Growth Rate (2015-2025)
Figure 17. South America Pharmacokinetics Revenue (Million USD) and Growth Rate (2015-2025)
Figure 18. Middle East and Africa Pharmacokinetics Revenue (Million USD) and Growth Rate (2015-2025)
Figure 19. Global Pharmacokinetics Revenue (Million USD) and Growth Rate (2015-2025)
Figure 20. Global Pharmacokinetics Revenue Share by Players in 2019
Figure 21. Global Top 5 Players Pharmacokinetics Revenue Market Share in 2019
Figure 22. Global Top 10 Players Pharmacokinetics Revenue Market Share in 2019
Figure 23. Key Players Market Share Trend
Figure 24. Global Pharmacokinetics Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 25. Global Pharmacokinetics Revenue Market Share by Regions (2015-2020)
Figure 26. Global Pharmacokinetics Revenue Market Share by Regions in 2018
Figure 27. North America Pharmacokinetics Revenue and Growth Rate (2015-2020)
Figure 28. Europe Pharmacokinetics Revenue and Growth Rate (2015-2020)
Figure 29. Asia-Pacific Pharmacokinetics Revenue and Growth Rate (2015-2020)
Figure 30. South America Pharmacokinetics Revenue and Growth Rate (2015-2020)
Figure 31. Middle East and Africa Pharmacokinetics Revenue and Growth Rate (2015-2020)
Figure 32. North America Pharmacokinetics Revenue Market Share by Countries (2015-2020)
Figure 33. North America Pharmacokinetics Revenue Market Share by Countries in 2019
Figure 34. USA Pharmacokinetics Revenue and Growth Rate (2015-2020)
Figure 35. Canada Pharmacokinetics Revenue and Growth Rate (2015-2020)
Figure 36. Mexico Pharmacokinetics Revenue and Growth Rate (2015-2020)
Figure 37. Europe Pharmacokinetics Revenue Market Share by Countries (2015-2020)
Figure 38. Europe Pharmacokinetics Revenue Market Share by Countries in 2019
Figure 39. Germany Pharmacokinetics Revenue and Growth Rate (2015-2020)
Figure 40. UK Pharmacokinetics Revenue and Growth Rate (2015-2020)
Figure 41. France Pharmacokinetics Revenue and Growth Rate (2015-2020)
Figure 42. Russia Pharmacokinetics Revenue and Growth Rate (2015-2020)
Figure 43. Italy Pharmacokinetics Revenue and Growth Rate (2015-2020)
Figure 44. Asia-Pacific Pharmacokinetics Revenue Market Share by Countries (2015-2020)
Figure 45. Asia-Pacific Pharmacokinetics Revenue Market Share by Countries in 2019
Figure 46. China Pharmacokinetics Revenue and Growth Rate (2015-2020)
Figure 47. Japan Pharmacokinetics Revenue and Growth Rate (2015-2020)
Figure 48. Korea Pharmacokinetics Revenue and Growth Rate (2015-2020)
Figure 49. India Pharmacokinetics Revenue and Growth Rate (2015-2020)
Figure 50. Southeast Asia Pharmacokinetics Revenue and Growth Rate (2015-2020)
Figure 51. South America Pharmacokinetics Revenue Market Share by Countries (2015-2020)
Figure 52. South America Pharmacokinetics Revenue Market Share by Countries in 2019
Figure 53. Brazil Pharmacokinetics Revenue and Growth Rate (2015-2020)
Figure 54. Argentina Pharmacokinetics Revenue and Growth Rate (2015-2020)
Figure 55. Middle East and Africa Pharmacokinetics Revenue Market Share by Countries (2015-2020)
Figure 56. Middle East and Africa Pharmacokinetics Revenue Market Share by Countries in 2019
Figure 57. Saudi Arabia Pharmacokinetics Revenue and Growth Rate (2015-2020)
Figure 58. UAE Pharmacokinetics Revenue and Growth Rate (2015-2020)
Figure 59. Egypt Pharmacokinetics Revenue and Growth Rate (2015-2020)
Figure 60. South Africa Pharmacokinetics Revenue and Growth Rate (2015-2020)
Figure 61. Global Pharmacokinetics Revenue Share by Type (2015-2020)
Figure 62. Global Pharmacokinetics Revenue Share by Type in 2019
Figure 63. Global Pharmacokinetics Market Share Forecast by Type (2021-2025)
Figure 64. Global Noncompartmental Methods Revenue Growth Rate (2015-2020)
Figure 65. Global Compartmental Methods Revenue Growth Rate (2015-2020)
Figure 66. Global Pharmacokinetics Revenue Share by Application (2015-2020)
Figure 67. Global Pharmacokinetics Revenue Share by Application in 2019
Figure 68. Global Pharmacokinetics Market Share Forecast by Application (2021-2025)
Figure 69. Global Oncology Revenue Growth Rate (2015-2020)
Figure 70. Global Cardiovascular Diseases Revenue Growth Rate (2015-2020)
Figure 71. Global Infectious Diseases Revenue Growth Rate (2015-2020)
Figure 72. Global Autoimmune Diseases Revenue Growth Rate (2015-2020)
Figure 73. Global Respiratory Disorders Revenue Growth Rate (2015-2020)
Figure 74. Global Neurological Disorders Revenue Growth Rate (2015-2020)
Figure 75. Global Others Revenue Growth Rate (2015-2020)
Figure 76. Global Pharmacokinetics Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 77. Global Pharmacokinetics Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 78. Global Pharmacokinetics Revenue Market Share Forecast by Regions (2021-2025)
Figure 79. North America Pharmacokinetics Revenue Market Forecast (2021-2025)
Figure 80. Europe Pharmacokinetics Revenue Market Forecast (2021-2025)
Figure 81. Asia-Pacific Pharmacokinetics Revenue Market Forecast (2021-2025)
Figure 82. South America Pharmacokinetics Revenue Market Forecast (2021-2025)
Figure 83. Middle East and Africa Pharmacokinetics Revenue Market Forecast (2021-2025)
Figure 84. Sales Channel: Direct Channel vs Indirect Channel
計算生物学の世界市場2020年：企業別、地域別、種類・用途別 Market Overview The global Computational Biology market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 10.6% in the forecast period of 2020 to 2025 and will expected to reach USD 3377.3 million by 2025, from USD 2256.9 million in 2019. The Computational…- 防振アイソレータの世界市場2020年：メーカー別、地域別、種類・用途別 Market Overview The global Vibration Isolators market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Vibration Isolators marke…
- 水処理システムの世界市場2020年：企業別、地域別、種類・用途別 Market Overview The global Water Treatment Systems market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 4.6% in the forecast period of 2020 to 2025 and will expected to reach USD 5527.2 million by 2025, from USD 4613.1 million in 2019. The Water Treatm…
- 獣医腫瘍の世界市場2020年：企業別、地域別、種類・用途別 Market Overview The Veterinary Oncology market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, t…
- 腫瘍学治療薬の世界市場2020年：企業別、地域別、種類・用途別 Market Overview The Drugs for Oncology market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, tr…